Triple

T5636382
Position Surface form Disambiguated ID Type / Status
Subject Japan–European Union relations E147958 entity
Predicate hasComponent P35 FINISHED
Object EU–Japan regulatory cooperation forum
The EU–Japan regulatory cooperation forum is a bilateral platform where the European Union and Japan coordinate and align regulatory policies to facilitate trade, investment, and mutual standards recognition.
E538638 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: EU–Japan regulatory cooperation forum | Statement: [Japan–European Union relations, hasComponent, EU–Japan regulatory cooperation forum]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: EU–Japan regulatory cooperation forum
Context triple: [Japan–European Union relations, hasComponent, EU–Japan regulatory cooperation forum]
  • A. European medicines regulatory authorities
    European medicines regulatory authorities are national and regional agencies in Europe responsible for evaluating, authorizing, and monitoring the safety, quality, and efficacy of medicinal products.
  • B. European Union medical device regulations
    European Union medical device regulations are a comprehensive set of legal and technical requirements governing the safety, performance, quality management, and market approval of medical devices within EU member states.
  • C. Working Party on Domestic Regulation
    The Working Party on Domestic Regulation is a specialized body within the World Trade Organization that focuses on developing and clarifying rules governing domestic regulatory measures affecting trade in services.
  • D. Global Technical Regulations under the 1998 Agreement
    Global Technical Regulations under the 1998 Agreement are internationally harmonized vehicle safety and environmental standards adopted by participating countries to ensure consistent regulatory requirements worldwide.
  • E. European Union pharmaceutical legislation
    European Union pharmaceutical legislation is the body of EU laws and regulations that governs the authorization, supervision, safety, and quality of medicines for human and veterinary use across member states.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: EU–Japan regulatory cooperation forum
Triple: [Japan–European Union relations, hasComponent, EU–Japan regulatory cooperation forum]
Generated description
The EU–Japan regulatory cooperation forum is a bilateral platform where the European Union and Japan coordinate and align regulatory policies to facilitate trade, investment, and mutual standards recognition.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: EU–Japan regulatory cooperation forum
Target entity description: The EU–Japan regulatory cooperation forum is a bilateral platform where the European Union and Japan coordinate and align regulatory policies to facilitate trade, investment, and mutual standards recognition.
  • A. European medicines regulatory authorities
    European medicines regulatory authorities are national and regional agencies in Europe responsible for evaluating, authorizing, and monitoring the safety, quality, and efficacy of medicinal products.
  • B. European Union medical device regulations
    European Union medical device regulations are a comprehensive set of legal and technical requirements governing the safety, performance, quality management, and market approval of medical devices within EU member states.
  • C. Working Party on Domestic Regulation
    The Working Party on Domestic Regulation is a specialized body within the World Trade Organization that focuses on developing and clarifying rules governing domestic regulatory measures affecting trade in services.
  • D. Global Technical Regulations under the 1998 Agreement
    Global Technical Regulations under the 1998 Agreement are internationally harmonized vehicle safety and environmental standards adopted by participating countries to ensure consistent regulatory requirements worldwide.
  • E. European Union pharmaceutical legislation
    European Union pharmaceutical legislation is the body of EU laws and regulations that governs the authorization, supervision, safety, and quality of medicines for human and veterinary use across member states.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69c00907bc8881909ed760d3ed73ef35 completed March 22, 2026, 3:21 p.m.
NER Named-entity recognition batch_69c022809f708190ab859aa446683b10 completed March 22, 2026, 5:10 p.m.
NED1 Entity disambiguation (via context triple) batch_69c04d70e5d88190b869d54911bc8689 completed March 22, 2026, 8:13 p.m.
NEDg Description generation batch_69c04e8a92a0819091bad1fbef4a509b completed March 22, 2026, 8:18 p.m.
NED2 Entity disambiguation (via description) batch_69c056acf1f48190bf7324ae178adbb7 completed March 22, 2026, 8:53 p.m.
Created at: March 22, 2026, 3:41 p.m.